1. Home
  2. SYBX vs ANY Comparison

SYBX vs ANY Comparison

Compare SYBX & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • ANY
  • Stock Information
  • Founded
  • SYBX N/A
  • ANY N/A
  • Country
  • SYBX United States
  • ANY United States
  • Employees
  • SYBX N/A
  • ANY N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • SYBX Health Care
  • ANY Finance
  • Exchange
  • SYBX Nasdaq
  • ANY Nasdaq
  • Market Cap
  • SYBX 20.0M
  • ANY 23.8M
  • IPO Year
  • SYBX N/A
  • ANY N/A
  • Fundamental
  • Price
  • SYBX $1.75
  • ANY $0.46
  • Analyst Decision
  • SYBX
  • ANY Strong Buy
  • Analyst Count
  • SYBX 0
  • ANY 1
  • Target Price
  • SYBX N/A
  • ANY $3.00
  • AVG Volume (30 Days)
  • SYBX 50.2K
  • ANY 737.1K
  • Earning Date
  • SYBX 11-11-2025
  • ANY 11-04-2025
  • Dividend Yield
  • SYBX N/A
  • ANY N/A
  • EPS Growth
  • SYBX N/A
  • ANY N/A
  • EPS
  • SYBX N/A
  • ANY N/A
  • Revenue
  • SYBX N/A
  • ANY $11,099,000.00
  • Revenue This Year
  • SYBX N/A
  • ANY N/A
  • Revenue Next Year
  • SYBX N/A
  • ANY $36.07
  • P/E Ratio
  • SYBX N/A
  • ANY N/A
  • Revenue Growth
  • SYBX N/A
  • ANY N/A
  • 52 Week Low
  • SYBX $0.90
  • ANY $0.36
  • 52 Week High
  • SYBX $1.96
  • ANY $1.67
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 49.98
  • ANY 27.42
  • Support Level
  • SYBX $1.52
  • ANY $0.45
  • Resistance Level
  • SYBX $1.86
  • ANY $0.65
  • Average True Range (ATR)
  • SYBX 0.12
  • ANY 0.06
  • MACD
  • SYBX -0.01
  • ANY -0.02
  • Stochastic Oscillator
  • SYBX 42.86
  • ANY 1.46

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: